{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T10:00:56Z","timestamp":1790330456413,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["HI15C2259"],"award-info":[{"award-number":["HI15C2259"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mycopathologia"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s11046-018-0271-8","type":"journal-article","created":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T10:14:23Z","timestamp":1527848063000},"page":"731-736","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["TR34\/L98H Mutation in CYP51A Gene in Aspergillus fumigatus Clinical Isolates During Posaconazole Prophylaxis: First Case in Korea"],"prefix":"10.1007","volume":"183","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2668-8918","authenticated-orcid":false,"given":"Hyeon-Jeong","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5392-3405","authenticated-orcid":false,"given":"Sung-Yeon","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Gun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chulmin","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye-Sun","family":"Chun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeon-Joon","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,1]]},"reference":[{"key":"271_CR1","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.drup.2015.08.001","volume":"21\u201322","author":"PE Verweij","year":"2015","unstructured":"Verweij PE, Ananda-Rajah M, Andes D, Arendrup MC, Br\u00fcggemann RJ, Chowdhary A, et al. International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatus. Drug Resist Updat. 2015;21\u201322:30\u201340.","journal-title":"Drug Resist Updat"},{"key":"271_CR2","first-page":"237","volume":"55","author":"SB Kim","year":"2017","unstructured":"Kim SB, Cho SY, Lee DG, Choi JK, Lee HJ, Kim SH, et al. Breakthrough invasive fungal diseases during voriconazole treatment for aspergillosis: A 5-year retrospective cohort study. Med Mycol. 2017;55:237\u201345.","journal-title":"Med Mycol"},{"issue":"3","key":"271_CR3","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1093\/cid\/civ885","volume":"62","author":"PE Verweij","year":"2016","unstructured":"Verweij PE, Chowdhary A, Merlchers WJ, Meis JF. Azole Resistance in Aspergillus fumigatus: can we retain the clinical use of mold-active antifungal azoles? Clin Infect Dis. 2016;62(3):362\u20138.","journal-title":"Clin Infect Dis"},{"key":"271_CR4","doi-asserted-by":"publisher","first-page":"e219","DOI":"10.1371\/journal.pmed.0050219","volume":"5","author":"E Snelders","year":"2008","unstructured":"Snelders E, van der Lee HA, Kuijpers J, Rijs AJ, Varga J, Samson RA, et al. Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism. PLoS Med. 2008;5:e219.","journal-title":"PLoS Med"},{"key":"271_CR5","doi-asserted-by":"publisher","first-page":"S436","DOI":"10.1093\/infdis\/jix210","volume":"216","author":"A Chowdhary","year":"2017","unstructured":"Chowdhary A, Sharma C, Meis JF. Azole-resistant aspergillosis: epidemiology, molecular mechanisms, and treatment. J Infect Dis. 2017;216:S436\u201344.","journal-title":"J Infect Dis"},{"key":"271_CR6","doi-asserted-by":"publisher","first-page":"e1003633","DOI":"10.1371\/journal.ppat.1003633","volume":"9","author":"A Chowdhary","year":"2013","unstructured":"Chowdhary A, Kathuria S, Xu J, Meis JF. Emergence of azole-resistant Aspergillus fumigatus strains due to agricultural azole use creates an increasing threat to human health. PLoS Pathog. 2013;9:e1003633.","journal-title":"PLoS Pathog"},{"key":"271_CR7","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.3389\/fmicb.2016.01382","volume":"7","author":"D Hagiwara","year":"2016","unstructured":"Hagiwara D, Watanabe A, Kamei K, Goldman GH. Epidemiological and genomic landscape of azole resistance mechanisms in aspergillus fungi. Front Microbiol. 2016;7:1382.","journal-title":"Front Microbiol"},{"key":"271_CR8","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"B Pauw De","year":"2008","unstructured":"De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group. Clin Infect Dis. 2008;46:1813\u201321.","journal-title":"Clin Infect Dis"},{"key":"271_CR9","doi-asserted-by":"publisher","first-page":"e40863","DOI":"10.1371\/journal.pone.0040863","volume":"7","author":"H Toju","year":"2012","unstructured":"Toju H, Tanabe AS, Yamamoto S, Sato H. High-coverage ITS primers for the DNA-based identification of ascomycetes and basidiomycetes in environmental samples. PLoS ONE. 2012;7:e40863.","journal-title":"PLoS ONE"},{"key":"271_CR10","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1128\/AEM.61.4.1323-1330.1995","volume":"61","author":"NL Glass","year":"1995","unstructured":"Glass NL, Donaldson GC. Development of primer sets designed for use with the PCR to amplify conserved genes from filamentous ascomycetes. Appl Environ Microbiol. 1995;61:1323\u201330.","journal-title":"Appl Environ Microbiol"},{"key":"271_CR11","unstructured":"Clinical and Laboratory Standards Institute. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi; Approved Standard\u2014Second Edition. CLSI document M38-A2. Wayne, PA: Clinical and Laboratory Standards Institute; 2008."},{"key":"271_CR12","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1093\/jac\/dks160","volume":"67","author":"F Morio","year":"2012","unstructured":"Morio F, Aubin GG, Danner-Boucher I, Haloun A, Sacchetto E, Garcia-Hermoso D, et al. High prevalence of triazole resistance in Aspergillus fumigatus, especially mediated by TR\/L98H, in a French cohort of patients with cystic fibrosis. J Antimicrob Chemother. 2012;67:1870\u20133.","journal-title":"J Antimicrob Chemother"},{"key":"271_CR13","doi-asserted-by":"publisher","first-page":"602","DOI":"10.3343\/alm.2015.35.6.602","volume":"35","author":"MS Heo","year":"2015","unstructured":"Heo MS, Shin JH, Choi MJ, Park YJ, Lee HS, Koo SH, et al. Molecular identification and amphotericin B susceptibility testing of clinical isolates of Aspergillus from 11 hospitals in Korea. Ann Lab Med. 2015;35:602\u201310.","journal-title":"Ann Lab Med"},{"key":"271_CR14","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.ijantimicag.2016.10.019","volume":"49","author":"P Koehler","year":"2017","unstructured":"Koehler P, Hamprecht A, Bader O, Bekeredjian-Ding I, Buchheidt D, Doelken G, et al. Epidemiology of invasive aspergillosis and azole resistance in patients with acute leukaemia: the SEPIA Study. Int J Antimicrob Agents. 2017;49:218\u201323.","journal-title":"Int J Antimicrob Agents"},{"key":"271_CR15","doi-asserted-by":"publisher","first-page":"4053","DOI":"10.1128\/AEM.00231-09","volume":"75","author":"E Snelders","year":"2009","unstructured":"Snelders E, Huis In \u2018t Veld RA, Rijs AJ, Kema GH, Melchers WJ, Verweij PE. Possible environmental origin of resistance of Aspergillus fumigatus to medical triazoles. Appl Environ Microbiol. 2009;75:4053\u20137.","journal-title":"Appl Environ Microbiol"},{"key":"271_CR16","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1093\/jac\/dku364","volume":"70","author":"J Ingen van","year":"2015","unstructured":"van Ingen J, van der Lee HA, Rijs TA, Zoll J, Leenstra T, Melchers WJ, et al. Azole, polyene and echinocandin MIC distributions for wild-type, TR34\/L98H and TR46\/Y121F\/T289A Aspergillus fumigatus isolates in The Netherlands. J Antimicrob Chemother. 2015;70:178\u201381.","journal-title":"J Antimicrob Chemother"},{"issue":"12","key":"271_CR17","doi-asserted-by":"publisher","first-page":"e109","DOI":"10.1038\/emi.2017.97","volume":"6","author":"S Deng","year":"2017","unstructured":"Deng S, Zhang L, Verweij PE, Tsui KM, Hagen F, Houbraken J, et al. Triazole phenotypes and genotypic characterization of clinical Aspergillus fumigatus isolates in China. Emerg Microbes Infect. 2017;6(12):e109.","journal-title":"Emerg Microbes Infect"},{"key":"271_CR18","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/myc.12440","volume":"59","author":"PP Lestrade","year":"2016","unstructured":"Lestrade PP, Meis JF, Arends JP, van der Beek MT, de Brauwer E, van Dijk K, et al. Diagnosis and management of aspergillosis in The Netherlands: a national survey. Mycoses. 2016;59:101\u20137.","journal-title":"Mycoses"},{"key":"271_CR19","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/ciw326","volume":"63","author":"TF Patterson","year":"2016","unstructured":"Patterson TF, Thompson GR 3rd, Denning DW, Fishman JA, Hadley S, Herbrecht R, et al. Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the infectious diseases society of America. Clin Infect Dis. 2016;63:e1\u2013e60.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"271_CR20","doi-asserted-by":"publisher","first-page":"e16","DOI":"10.1093\/cid\/cir485","volume":"53","author":"C Garcia-Vidal","year":"2011","unstructured":"Garcia-Vidal C, Barba P, Arnan M, Moreno A, Ruiz-Camps I, Gudiol C, et al. Invasive aspergillosis complicating pandemic influenza A (H1N1) infection in severely immunocompromised patients. Clin Infect Dis. 2011;53(6):e16\u20139.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"271_CR21","doi-asserted-by":"publisher","first-page":"971","DOI":"10.3201\/eid1606.100165","volume":"16","author":"A Lat","year":"2010","unstructured":"Lat A, Bhadelia N, Miko B, Furuya EY, Thompson GR 3rd. Invasive aspergillosis after pandemic (H1N1) 2009. Emerg Infect Dis. 2010;16(6):971\u20133.","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"271_CR22","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3947\/ic.2013.45.2.225","volume":"45","author":"MJ Kim","year":"2013","unstructured":"Kim MJ, Kim MK, Kang CK, Jun KI, Bang JH, Park SW, et al. A case of acute cerebral aspergillosis complicating influenza A\/H1N1pdm 2009. Infect Chemother. 2013;45(2):225\u20139.","journal-title":"Infect Chemother"},{"issue":"6","key":"271_CR23","doi-asserted-by":"publisher","first-page":"260","DOI":"10.4046\/trd.2013.75.6.260","volume":"75","author":"OK Kwon","year":"2013","unstructured":"Kwon OK, Lee MG, Kim HS, Park MS, Kwak KM, Park SY. Invasive pulmonary aspergillosis after influenza a infection in an immunocompetent patient. Tuberc Respir Dis Seoul. 2013;75(6):260\u20133.","journal-title":"Tuberc Respir Dis Seoul"},{"key":"271_CR24","doi-asserted-by":"publisher","unstructured":"van de Veerdonk FL, Kolwijck E, Lestrade PP, Hodiamont CJ, Rijnders BJ, van Paassen J et al. Influenza-associated aspergillosis in critically ill patients. Am J Respir Crit Care Med. 2017 Apr 7. https:\/\/doi.org\/10.1164\/rccm.201612-2540le (Epub ahead of print).","DOI":"10.1164\/rccm.201612-2540le"},{"issue":"5","key":"271_CR25","doi-asserted-by":"publisher","first-page":"R167","DOI":"10.1186\/cc9259","volume":"14","author":"JF Bermejo-Martin","year":"2010","unstructured":"Bermejo-Martin JF, Martin-Loeches I, Rello J, Ant\u00f3n A, Almansa R, Xu L, et al. Host adaptive immunity deficiency in severe pandemic influenza. Crit Care. 2010;14(5):R167.","journal-title":"Crit Care"},{"key":"271_CR26","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.3201\/eid1710.110226","volume":"17","author":"JW Linden van der","year":"2011","unstructured":"van der Linden JW, Snelders E, Kampinga GA, Rijnders BJ, Mattsson E, Debets-Ossenkopp YJ, et al. Clinical implications of azole resistance in Aspergillus fumigatus, The Netherlands, 2007\u20132009. Emerg Infect Dis. 2011;17:1846\u201354.","journal-title":"Emerg Infect Dis"}],"container-title":["Mycopathologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11046-018-0271-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-018-0271-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-018-0271-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T00:24:57Z","timestamp":1604363097000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11046-018-0271-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,1]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["271"],"URL":"https:\/\/doi.org\/10.1007\/s11046-018-0271-8","relation":{},"ISSN":["0301-486X","1573-0832"],"issn-type":[{"value":"0301-486X","type":"print"},{"value":"1573-0832","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,1]]},"assertion":[{"value":"25 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Institutional Review Board of Seoul St. Mary\u2019s Hospital at the Catholic University of Korea with a waiver of informed consent (IRB No. KC16SISI0307) due to anonymous and retrospective design of the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Standards"}}]}}